Uncontrolled Blood Pressure and Reduced Kidney Function Increase Risk of Advanced Fibrosis in Patients with MASLD
The following is a summary of “Objective measures of cardiometabolic risk and advanced fibrosis risk progression in primary care patients with metabolic dysfunction-associated steatotic liver disease,” published in the August 2024 issue of Endocrinology by...